Male Breast Cancer Terminated Phase 1 Trials for Alvocidib (DB03496)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00039455Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast CancerTreatment